Vireo Growth (VREOF) Gross Margin (2020 - 2026)

Vireo Growth (VREOF) reported Gross Margin of 55.84% for Q1 2026, up 523.0% on a YoY basis from 8.96% in Q1 2025, and up 2.59% sequentially from 54.43% in Q4 2025.

Vireo Growth (VREOF) Gross Margin (2020 - 2026) Analysis & Trends

Vireo Growth (VREOF) has 7 years of Gross Margin data on file, last reported at 55.84% in Q1 2026.

  • For the quarter ending Q1 2026, Gross Margin rose 523.0% year-over-year to 55.84%; the trailing twelve-month figure through Mar 2026 stood at 49.65% (down 138.0% YoY), and the FY2025 full-year result was 47.29%, down 380.0% from the prior year.
  • Gross Margin improved to 55.84% in Q1 2026, from 54.43% in the prior quarter.
  • In the past five years, Gross Margin ranged from a high of 55.84% in Q1 2026 to a low of 15.91% in Q1 2022.
  • A 5-year average of 47.55% and a median of 49.87% in 2023 frame the typical range for Gross Margin.
  • Across the five-year window, Gross Margin tumbled 2666 bps in 2022 and jumped 3396 bps in 2023, its largest moves.
  • Tracing VREOF's Gross Margin over 5 years: stood at 44.72% in 2022, then gained by 12 bps to 49.87% in 2023, then grew by 1 bps to 50.56% in 2024, then advanced by 8 bps to 54.43% in 2025, then rose by 3 bps to 55.84% in 2026.
  • Business Quant data shows VREOF's Gross Margin at 55.84% in Q1 2026, 54.43% in Q4 2025, and 40.79% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 49.52%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 71.66%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 62.93%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 82.93%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 32.97%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 98.31%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 57.26%
10 Vireo Growth 10.57 Bn 10.41 Bn 59.30 Mn 55.84%

Historic Data

Download Data
DateValue
Mar 31, 2026 55.84%
Dec 31, 2025 54.43%
Sep 30, 2025 40.79%
Jun 30, 2025 42.48%
Mar 31, 2025 50.61%
Dec 31, 2024 50.56%
Sep 30, 2024 48.97%
Jun 30, 2024 53.97%
Mar 31, 2024 50.83%
Dec 31, 2023 49.87%
Sep 30, 2023 53.48%
Jun 30, 2023 46.20%
Mar 31, 2023 49.87%
Dec 31, 2022 44.72%
Sep 30, 2022 50.58%
Jun 30, 2022 49.16%
Mar 31, 2022 15.91%
Dec 31, 2021 15.78%
Sep 30, 2021 38.26%
Jun 30, 2021 48.58%